
Keywords: تری فسفات دز اکسید ریبونوکلئوتید; ALT; alternative lengthening of telomeres; CDK; cyclin-dependent kinase; DDR; DNA damage response; dNTP; deoxyriboNucleotide TriPhosphate; DPC; DNA-protein crosslink; DSB; double-strand break; FDA; Food and Drug Administration; HRR; homologous recombinati